home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

204 rows where filing_period = "third_quarter", filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: is_termination, received_date (date)

issue_code 1

  • PHA · 204 ✖

filing_year 1

  • 2011 · 204 ✖

filing_period 1

  • third_quarter · 204 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1143231 BELL POTTINGER USA a238906b-b56d-444b-b5d0-0a72ba971ed6 3T BELL POTTINGER USA 400703108 LEO PHARMA INC. 2011 third_quarter PHA Engage FDA, CDC and Hill policy-makers on behalf of the client to support regulatory and outreach efforts in the US. HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2011-08-12T11:46:09.650000-04:00
1144784 R.G. FLIPPO AND ASSOCIATES, INC 226ad98b-bd49-4579-b6cd-4d6edb68699f Q3 R.G. FLIPPO AND ASSOCIATES, INC 14861 ALABAMA NURSING HOME ASSOCIATION 2011 third_quarter PHA S. 1560 Nursing Home Resident Pain Relief Act of 2011 HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2011-10-04T15:37:07.143000-04:00
1144788 INDEPENDENT PHARMACY COOPERATIVE 092bc8e0-b865-4521-adde-d3347b6b560c Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2011 third_quarter PHA DEA Physician/Nurse Agent Definition. CMS Average Acquisition Cost (AAC) Methodology. S. 274 The Medication Management Empowerment Act of 2011. All provisions S. 1002 Prohibit Theft of Medical Products 2011. All provisions Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2011-10-04T16:02:15.797000-04:00
1144796 AMERICAN FOUNDATION FOR THE BLIND bab1a9b7-308d-40e7-b0d1-845d7431a8d0 Q3 AMERICAN FOUNDATION FOR THE BLIND 2401 AMERICAN FOUNDATION FOR THE BLIND 2011 third_quarter PHA Prescription Drug labeling Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-04T16:40:23.753000-04:00
1144846 AMERICAN COLLEGE OF CLINICAL PHARMACY 34947c73-2a84-4032-9ca2-13ecde8cf4b2 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-10-05T09:52:10.183000-04:00
1144879 CYBER SECURITY RESEARCH CONSULTANTS, LLC 26a4dab1-dd02-457b-9bc3-5d9ad5e38cb5 Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2011 third_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act HOUSE OF REPRESENTATIVES,SENATE 21000   0 0 2011-10-05T11:08:34.337000-04:00
1144892 MEREDITH MCGEHEE 49dabc70-d848-4060-bb8f-80ee38708b34 3T MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2011 third_quarter PHA Funding for programs to develop AIDS vaccines targeted toward the developing world; Educating about research and development programs aimed at AIDS epidemic and other global health issues; Appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's PDP model; Providing input regarding foreign assistance reform from global health perspective; FUnding and budget issues related to USAID R&D. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2011-10-05T11:30:42.837000-04:00
1145161 SHELTER ROCK STRATEGIES, LLC 61f6815a-48b2-4017-8d40-26377706818c Q3 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2011 third_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-06T10:01:15.977000-04:00
1145165 INJURED WORKERS PHARMACY 7138f6b7-32ec-426b-99be-daa2c2552a6e Q3 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2011 third_quarter PHA Transparency of Pharmacy Benefit Managers (Bill sponosred by Rep. McMorris Rodgers and Sen. Mark Pryor; Longshoer and Harbor Workers Amendment Act of 2011 sponsored by Sen. Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-06T10:20:21.633000-04:00
1145485 PARRY, ROMANI, DECONCINI & SYMMS 74d490fb-2f3f-4b79-823b-cc8bab103fb5 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2011 third_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2011-10-07T12:41:41.980000-04:00
1146008 RED+BLUE STRATEGIES 9f9d403e-615b-4a80-bfac-86f149373841 Q3 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2011 third_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-10-10T14:46:19.470000-04:00
1146053 RED+BLUE STRATEGIES 1762f489-58b5-44b4-82cb-0bce55aa72c6 Q3 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2011 third_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Trade Representative (USTR) 40000   0 0 2011-10-10T15:30:41.280000-04:00
1146430 PUBLIC AFFAIRS RESOURCES, INC. 4f9870d9-a516-404b-bb81-4a84813fe7e1 Q3 PUBLIC AFFAIRS RESOURCES, INC. 31270 PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) 2011 third_quarter PHA Electronic Professional Inserts in lieu of Paper, FDA HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-11T12:52:40.833000-04:00
1146455 THE OB-C GROUP, LLC 4dfcdcc0-13dc-4c86-8dc4-e1a5ca6b3702 Q3 THE OB-C GROUP, LLC 29802 ELI LILLY 2011 third_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-11T13:20:26.393000-04:00
1146469 LONG TERM CARE PHARMACY ALLIANCE 0df3bcf9-262b-4f07-9772-9d4c084e5931 Q3 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2011 third_quarter PHA Medicare Part D Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2011-10-11T13:42:37.050000-04:00
1146614 NAHIGIAN STRATEGIES, LLC 6eb4f9a6-8672-4d0e-8c8b-6307af1f1abf Q3 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2011 third_quarter PHA Generic Drug issues Generally HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-11T15:23:10.177000-04:00
1146905 ACADEMY OF MANAGED CARE PHARMACY aaf6fb28-78f1-4f01-90b5-e8ab7fc8663d Q3 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2011 third_quarter PHA S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product. HR 1483 - legislation that would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act S 296 and HR 2245 - legislation that would address shortages of prescription drugs HR 2746 - legislation that would require cost-sharing parity between all cancer medications within pharmacy benefits regulated under ERISA. HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program. HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2011-10-12T10:14:35.163000-04:00
1147636 NOVO NORDISK INC. f36b85f5-586c-4d2b-a5be-7fd747027a6d Q3 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2011 third_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE   910000 0 0 2011-10-13T10:12:23.790000-04:00
1147704 CAPITOL HILL CONSULTING GROUP cad5255c-e7d7-4214-93f9-007858ee09f1 Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2011 third_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-13T11:04:04.507000-04:00
1147719 DUTKO WORLDWIDE, LLC d8aab9bb-663c-4fa9-bba4-e078c2376897 Q3 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2011 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-13T11:12:12.850000-04:00
1147779 EXPRESS SCRIPTS, INC. 9e0066da-1d41-47fb-98d8-8e0ce3eb84c3 Q3 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2011 third_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058). Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,U.S. Trade Representative (USTR),White House Office   380000 0 0 2011-10-13T11:48:40.817000-04:00
1147863 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK c28f66d8-90c2-4e0d-b3de-953ff87e2e08 Q3 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2011 third_quarter PHA Support legislation that would allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-13T12:52:23.190000-04:00
1147945 BUCHANAN INGERSOLL & ROONEY PC a08b37c2-66bc-4d73-8c34-0c3287bb3e0c Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 SHIRE PHARMACEUTICALS INC 2011 third_quarter PHA Life Sciences Investment Act; ESRD bundling, ESRD Quality Incentive program; orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-13T13:16:51.163000-04:00
1148378 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1ead4c84-5b03-4662-bb19-e80415fda570 Q3 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2011 third_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   18836 0 0 2011-10-13T16:30:00.950000-04:00
1149474 FOLEY & LARDNER LLP f8628f61-0660-41d2-96ec-1d465817c7cc Q3 FOLEY & LARDNER LLP 15042 ROMARK LABORATORIES, LC 2011 third_quarter PHA Sale of new anti-viral drug Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-14T15:28:47.940000-04:00
1149711 GOVBIZ ADVANTAGE, INC. 6af8645d-ea62-412b-992e-dc7eb3c76591 Q3 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2011 third_quarter PHA Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-14T16:59:11.500000-04:00
1149760 VENABLE LLP 2432ced9-d54e-4fa4-bc33-c080648f1dbb Q3 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2011 third_quarter PHA General issues affecting the pharmaceutical industry The Life Sciences Investment Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-14T17:32:41.580000-04:00
1149764 PRIME THERAPEUTICS 8eb0c437-c1be-4815-b237-20192f83fb92 Q3 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2011 third_quarter PHA HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2011-10-14T17:34:44.063000-04:00
1150147 HEARTLAND SOLUTIONS GROUP, INC. 912ce255-e8bd-4c79-8337-e7fef5d8a5e1 Q3 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2011 third_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. Army, Dept of (Other),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-10-16T18:55:25.103000-04:00
1150864 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 011af3e5-b0d4-4a7f-95c2-7488af7a44c9 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2011 third_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2011-10-17T12:53:39.483000-04:00
1150911 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3ea52269-8e4a-4232-b2f3-6227f856e7fe Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2011 third_quarter PHA Issues related to drug shortages. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-10-17T13:02:55.513000-04:00
1151139 PARRY, ROMANI, DECONCINI & SYMMS 9e878fe1-f6fa-4160-ad8f-1275a08de954 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T14:27:27.150000-04:00
1151185 PARRY, ROMANI, DECONCINI & SYMMS 128133c7-36ec-4fb9-8aa1-c54f21cf7ff1 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-10-17T14:36:45.987000-04:00
1151206 POLICY DIRECTIONS INC. d8ab9f4f-abe5-4c21-9526-2e9b533bbfde Q3 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2011 third_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-17T14:39:55.943000-04:00
1151422 PARRY, ROMANI, DECONCINI & SYMMS 083d9071-19ea-483c-bfd0-464b908be417 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:22:15.357000-04:00
1151452 PARRY, ROMANI, DECONCINI & SYMMS 9b1a94b1-063d-442e-9416-24e4290aeeb5 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:28:25.090000-04:00
1151514 GREATER NEW YORK HOSPITAL ASSOCIATION 15e07a06-1019-42f8-a4d3-d5ec9f4294f4 Q3 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2011 third_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations. Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   240000 0 0 2011-10-17T15:36:42.017000-04:00
1151516 PARRY, ROMANI, DECONCINI & SYMMS 5d125bb2-465d-433b-bbe4-a640a626165f Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:37:42.997000-04:00
1151518 THORN RUN PARTNERS 54a85fed-7611-444f-904c-8dec2e6eea2e Q3 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2011 third_quarter PHA Issues related to the implementation of the Affordable Care Act (ACA) and DEA enforcement of controlled substances in nursing homes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-17T15:37:43.653000-04:00
1151542 MCKENNA, LONG & ALDRIDGE d4d14ff9-e570-4256-ad85-4a6992f58918 Q3 MCKENNA, LONG & ALDRIDGE 76913 REVANCE THERAPEUTICS, INC. 2011 third_quarter PHA Any issues impacting biopharmaceutical companies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-17T15:45:58.483000-04:00
1151643 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 25b33942-a0bc-418e-8d74-68a1902a46ab Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2011 third_quarter PHA H.R. 979, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2011, legislation to reform oversight authority for OPM for the FEHBP drug benefit; H.R. 891 and S. 274, the Medication Therapy Management Benefits Act of 2011, which would expand beneficiary access to MTM services under Part D; H.R. 1041, the Fairness in Medicare Bidding Act, this legislation would repeal the competitive bidding program, in the Medicare Part B durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) program; S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011, this legislation expands transparency requirements for PBMs and limits certain audit practices by PBMs; H.R. 1936, the Medicare Access to Diabetes Act of 2011, legislation exempts small pharmacies from the DME competitive bidding program for diabetes test supplies; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011, would provide a narrow anti-trust exemption to allow small pharmacies to form pools to negotiate with PBMs; HR. 1409, the Quality Health Care Coalition Act of 2011, legislation would exempt health care professionals from federal antitrust laws for the purposes of contract negotiations with health plans; H.R. 1839, the Community Pharmacy Fairness Act, legislation would provide a narrow anti-trust exemption, which would allow groups of independent pharmacies to negotiate PBM contracts; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program, and for other purposes; Worked with Senate Finance and House Energy and Commerce staff on addressing questions raised by GAO regarding a study being conducted on the 3408 drug program as well as educating staff on the current 340b program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; H.R. 1540 and S. 1253, the National Defense Authorization Act for FY 12, includes funding for the TRICARE pharmacy program… Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   178134 0 0 2011-10-17T16:13:34.810000-04:00
1152032 LOCKE LORD PUBLIC POLICY GROUP LLC 3b475ca8-409f-415e-b0c9-938c6411cbc8 Q3 LOCKE LORD PUBLIC POLICY GROUP LLC 300971 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2011 third_quarter PHA Pharmceutical performance reimbursement; biogenics HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T17:30:12.213000-04:00
1152294 RUBICON ADVISORS, LLC daf93488-a19c-4038-bf45-6a2da917b9bc Q3 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2011 third_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2011-10-17T19:51:44.363000-04:00
1152295 RUBICON ADVISORS, LLC fe0ef7e1-f242-4bde-889d-ae8efe059261 Q3 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2011 third_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2011-10-17T20:01:44.877000-04:00
1152296 RUBICON ADVISORS, LLC 3ba1843b-7f49-4544-8cc5-da576d0d0fd4 Q3 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2011 third_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 HOUSE OF REPRESENTATIVES,SENATE 98000   0 0 2011-10-17T20:06:45.467000-04:00
1152297 RUBICON ADVISORS, LLC d5322948-a8cd-48fb-a5b2-98d46e512d3c 3T RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2011 third_quarter PHA Generic Biologics S. 1695 Affordable Health Care Choices Act HOUSE OF REPRESENTATIVES,SENATE     0 1 2011-10-17T20:10:46.057000-04:00
1152299 RUBICON ADVISORS, LLC 12c41d8a-211a-4ade-9cb8-6427f5fbd1a0 3T RUBICON ADVISORS, LLC 315091 OSMOTICA PHARMACEUTICALS 2011 third_quarter PHA FDA Citizen Petition Reform Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE     0 1 2011-10-17T20:16:46.650000-04:00
1152300 RUBICON ADVISORS, LLC 3aa9283a-6223-48d7-b5c8-f3506e2fdf47 Q3 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2011 third_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T20:21:47.243000-04:00
1152301 RUBICON ADVISORS, LLC b2f569f3-4540-4336-b479-3f7594779777 3T RUBICON ADVISORS, LLC 315091 CHILDREN'S HOSPITAL AND RESEARCH CENTER 2011 third_quarter PHA Health Care HOUSE OF REPRESENTATIVES,SENATE     0 1 2011-10-17T20:26:48.447000-04:00
1152765 FAEGRE BAKER DANIELS CONSULTING 300e5b70-55b8-493f-bd39-5311f998f0a2 Q3 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2011 third_quarter PHA ONLINE PHARMACIES Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-18T09:35:45.433000-04:00
1152910 MCDERMOTT WILL & SCHULTE LLP 460799c1-9fe4-44af-bab8-e031450f4918 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2011 third_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-18T10:07:40.283000-04:00
1153168 MCDERMOTT WILL & SCHULTE LLP fbd18a4d-7393-4cd4-bd7f-0ba0ebd0ace5 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2011 third_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 95000   0 0 2011-10-18T10:38:27.603000-04:00
1153241 THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 795ce075-8198-49f7-bcb1-5c105b5ba169 Q3 THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 18672 HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 2011 third_quarter PHA S. 296, Preserving Access to Life-Saving Medications H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011 HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2011-10-18T10:49:00.667000-04:00
1153295 STRATEGIES 360 b489989a-4841-4128-876d-843f77257d68 Q3 STRATEGIES 360 79175 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2011 third_quarter PHA Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars, Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-18T10:56:24.887000-04:00
1153336 EISAI INC. 925f7618-5274-4581-ba80-eb6536eb0c3e Q3 EISAI INC. 400321512 EISAI INC. 2011 third_quarter PHA Prescription Drug User Fee Act reauthorization. FDA-DEA issues Maintain current 340B program Maintain current exclusivity period for innovator biologics Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE   785000 0 0 2011-10-18T11:02:46.637000-04:00
1153703 BLUECROSS BLUESHIELD OF TENNESSEE 69cfe056-e3b6-4872-b27b-9eabc88ff37d Q3 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2011 third_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2011-10-18T12:05:15.947000-04:00
1154188 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2494dd9d-17e5-4b37-bc94-94c9f2c33ecd Q3 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2011 third_quarter PHA HR 2674 Supportive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340B discounts to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   71787 0 0 2011-10-18T13:30:21.100000-04:00
1154523 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) a8272b56-8adb-472a-be5b-ab2226c438cb Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2011 third_quarter PHA Importationof prescription drugs (S.319, H.R. 147), Rx Pedigree (H.R. 3026), Methamphetamine/Pseudoephedrine Regulation, NASPER Reauthorization (H.R. 866), Pill Mill Crackdown Act (H.R. 1065), Drug Abuse (S.507), Drug Shortages (S. 296/H.R. 2245), Cargo/Product Theft (S. 1002), Import Safety (S. 1584) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   264000 0 0 2011-10-18T14:18:44.467000-04:00
1154611 UNIVERSITY OF CONNECTICUT f38e285b-99dc-4705-af40-8aaced6cc0dd Q3 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2011 third_quarter PHA FDA salaries and expense; and extramural research related issues: H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2011-10-18T14:28:20.667000-04:00
1154627 MCDERMOTT WILL & SCHULTE LLP 0e66da02-3012-4a12-9b4c-ceab8527cda8 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2011 third_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2011-10-18T14:31:28.007000-04:00
1154933 EMPIRE CONSULTING GROUP 3910e32a-af0d-43b4-8154-3c706f4ecb22 Q3 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2011 third_quarter PHA Proposals relating to Medicare Part D; proposals relating to the Independent Payment Advisory Board ("IPAB"); and "super committee" deficit reductions proposals. HOUSE OF REPRESENTATIVES 30000   0 0 2011-10-18T14:59:23.710000-04:00
1154941 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c44b8a0d-b4bd-4cc5-b910-18881cc75177 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2011 third_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-18T15:00:27.523000-04:00
1155013 WINSTON & STRAWN LLP 8125d281-4704-4305-a7c7-37f9242bb8c0 Q3 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2011 third_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. Legislation of interest includes the America Invents Act of 2011 (H.R. 1249). HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2011-10-18T15:06:00.037000-04:00
1155178 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2ffc6f6a-d92f-493c-baa2-e275c9c68035 Q3 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2011 third_quarter PHA FDA proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements Comments to FDA on proposal regarding disclosures for online prescription drug advertising Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   280000 0 0 2011-10-18T15:17:07.943000-04:00
1155186 THE UNITED STATES PHARMACOPEIAL CONVENTION 4c784ef0-65db-4606-a869-42c4dea51550 Q3 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2011 third_quarter PHA - Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2011-10-18T15:18:10.287000-04:00
1155450 BROWN RUDNICK LLP 595242a1-eac0-4041-af00-5da16eb817a5 Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2011 third_quarter PHA Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-18T15:43:10.633000-04:00
1157149 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION e46ea49c-fc74-49f2-b420-609bb1255c61 Q3 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2011 third_quarter PHA Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. HOUSE OF REPRESENTATIVES,SENATE   205000 0 0 2011-10-19T09:32:25.423000-04:00
1157211 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 4d20993c-d808-49f7-9dd9-cafe8fca8e8a Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 GENENTECH 2011 third_quarter PHA Monitor Drug Safety and pedigree legislation Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-10-19T09:41:47.640000-04:00
1157364 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 2fa46219-a6b9-4517-998a-60fe9cb124f2 Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 NOVO NORDISK 2011 third_quarter PHA P.L. 111-148- Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152- The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-10-19T10:08:50.343000-04:00
1157647 NATIONAL RURAL HEALTH ASSOCATION eaffe4bf-0379-4be4-b698-28d62b4d4c02 Q3 NATIONAL RURAL HEALTH ASSOCATION 53048 NATIONAL RURAL HEALTH ASSOCATION 2011 third_quarter PHA Support for 340B drug program, expansion in health reform, and implementation. Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   11424 0 0 2011-10-19T10:44:33.463000-04:00
1158057 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 0bf76cac-39be-450c-864c-37c29841dcff Q3 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2011 third_quarter PHA S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE   440000 0 0 2011-10-19T11:35:19.773000-04:00
1158162 ELI LILLY AND COMPANY 50b6b86e-4873-4e83-a5b8-6fa4fd02adaf Q3 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2011 third_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   2325000 0 0 2011-10-19T11:58:00.710000-04:00
1158166 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 2fcb9bbd-583b-48c6-aa81-9931c8ab531e Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 ALTRIA CLIENT SERVICES INC 2011 third_quarter PHA Prescription Drug User Fee Act (PDUFA) reauthorization. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2011-10-19T11:58:01.680000-04:00
1158931 UNIVERSITY OF IOWA f7adc2b8-4875-4e08-8fc9-b8b1f0df246b Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2011 third_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2011-10-19T14:29:01.677000-04:00
1159029 BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC badcedab-d477-4f82-ac6c-a16ead251830 Q3 BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC 292972 BOEHRINGER INGELHEIM USA CORPORATION 2011 third_quarter PHA Reauthorization of the Prescription Drug User Fee Act; Drug Safety HOUSE OF REPRESENTATIVES,SENATE   530000 0 0 2011-10-19T14:34:46.067000-04:00
1159405 MARSHFIELD CLINIC HEALTH SYSTEM 35e3185b-0dc2-470e-9ee2-a2eff0499d85 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2011 third_quarter PHA Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   130000 0 0 2011-10-19T14:51:09.190000-04:00
1159587 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 0052a5d9-9364-42de-9b3a-51c1b26ee06f Q3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2011 third_quarter PHA Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2011-10-19T15:02:23.783000-04:00
1159612 BUCHANAN INGERSOLL & ROONEY PC 49e249c4-4678-49d8-a394-4bc82890c6be Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2011 third_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-19T15:03:32.720000-04:00
1159887 HANCE SCARBOROUGH 79abd5cc-bc7f-44d2-abb3-f9eabf062c3f Q3 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2011 third_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-19T15:16:13.017000-04:00
1160208 HANCE SCARBOROUGH 246d7954-0e5d-4bef-ba4b-da4ff85b5985 Q3 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2011 third_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-19T15:32:24.903000-04:00
1160514 WHITMER & WORRALL, LLC ab3ec5d8-8464-48b9-9aee-ce1139dedda0 Q3 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2011 third_quarter PHA Issues related to monitoring healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-19T15:47:23.813000-04:00
1160698 DOW LOHNES GOVERNMENT STRATEGIES LLC b09d8f56-69a0-4ae3-ac0f-171400fe80c6 Q3 DOW LOHNES GOVERNMENT STRATEGIES LLC 316013 AMERISOURCEBERGEN CORPORATION 2011 third_quarter PHA Legislative proposals related to pharmaceutical pedigree anti-counterfeiting, wholesale transaction documentation, and electronic tracking, including H.R. 1483, H.R. 3026, and S. 1584; legislative proposals related to drug shortages, including H.R. 2245 and S. 296. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-19T15:56:34.610000-04:00
1160860 BUCHANAN INGERSOLL & ROONEY PC 304a23cf-0fc4-41fe-9371-1896d1413c3c Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 IPEC - AMERICAS, INC. 2011 third_quarter PHA FDA Globalization Acts and legislation related to supply chain security and drug contamination issues Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-19T16:08:35.907000-04:00
1160870 THE RUSSELL GROUP, INC. 67be1fa0-4883-47cf-85d1-57f7c4d36ec0 Q3 THE RUSSELL GROUP, INC. 22688 GENERIC PHARMACEUTICAL ASSOCIATION 2011 third_quarter PHA Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 50000   0 0 2011-10-19T16:09:40.407000-04:00
1160885 BUCHANAN INGERSOLL & ROONEY PC 6a850300-2adf-4ab6-a01b-80704149c0fa Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO 2011 third_quarter PHA Patent reform, drug importation; Life Science Investment Act; drug exception from Pharma fee; medical device tax. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-19T16:11:47.483000-04:00
1161037 340B HEALTH d4fe6c2b-72aa-448a-9977-b228c4994dfe Q3 340B HEALTH 316434 340B HEALTH 2011 third_quarter PHA Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities. Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   221204 0 0 2011-10-19T16:25:36.810000-04:00
1161112 ASSOCIATION FOR ACCESSIBLE MEDICINES a3628046-2bcc-47fc-9afd-7070ec87dab5 Q3 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2011 third_quarter PHA FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office   548315 0 0 2011-10-19T16:34:06.983000-04:00
1161296 ASTRAZENECA PHARMACEUTICALS LP 152ed980-6806-4a2f-8c52-35afe3714aa7 Q3 ASTRAZENECA PHARMACEUTICALS LP 54073 ASTRAZENECA PHARMACEUTICALS LP 2011 third_quarter PHA HR 2112, HR 2190, S1206 - Proposed legislation regarding FDA appropriations FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) (no bill number yet) Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office   1410000 0 0 2011-10-19T16:50:11.387000-04:00
1161423 GENZYME CORPORATION c35077b4-db9d-49d2-acd1-6235f11bf924 Q3 GENZYME CORPORATION 16054 GENZYME CORPORATION 2011 third_quarter PHA S.606/H.R. 3059 - Creating Hope Act of 2011 Prescription Drug User Fee Act Reauthorization S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act H.R. 2482, Drug Safety Enhancement Act HOUSE OF REPRESENTATIVES,SENATE   460000 0 0 2011-10-19T17:06:11.277000-04:00
1161911 UPS (UNITED PARCEL SERVICE) adaf6f7e-418b-41ad-94b3-4f944896e54f Q3 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2011 third_quarter PHA - S.1984/HR 3026 FDA Track and Trace - Pedigree - Serialization Commerce, Dept of (DOC),Defense, Dept of (DOD),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   978161 0 0 2011-10-19T17:58:45.507000-04:00
1162316 C2 GROUP, LLC e9f77976-2fa2-4414-8a64-3a1b27304d7b Q3 C2 GROUP, LLC 66693 PERRIGO INC 2011 third_quarter PHA OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-19T19:00:06.377000-04:00
1162410 OMNICARE, INC. 9a6a9018-a345-4524-a9e6-4de3abef345c Q3 OMNICARE, INC. 321112 OMNICARE INC 2011 third_quarter PHA Encouraging consideration of SB 1560; related to ensuring access to pain medication to nursing home residents. HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2011-10-19T19:29:12.517000-04:00
1162451 KNIGHT CAPITOL CONSULTANTS b70aa75d-d846-471d-a40e-6c529cc35d4a Q3 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2011 third_quarter PHA S. 606, Creating Hope Act of 2011 S. 296/H.R. 2245, Preserving Access to Life-Saving Medication Act Reauthorization of the Prescription Drug User Fee Act and possible amendments thereto (no legislation yet) HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-19T19:42:32.737000-04:00
1162562 SHIRE PHARMACEUTICALS LLC 3890b669-0f7c-4af0-aeb2-2d65bbd7cba3 Q3 SHIRE PHARMACEUTICALS LLC 323477 SHIRE PHARMACEUTICALS LLC 2011 third_quarter PHA Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas SENATE   80000 0 0 2011-10-19T20:14:18.343000-04:00
1162886 SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) e6b14fae-9334-4377-a1d4-2820bfa7aa7c Q3 SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) 55223 COVERMYMEDS 2011 third_quarter PHA Prescription drug prior authorizations and other insurance coverage determinations. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS) 30000   0 0 2011-10-19T22:33:18.207000-04:00
1162975 KAR ASSOCIATES, LLC 58f68964-6fe5-4105-a273-b4d34956931f Q3 KAR ASSOCIATES, LLC 45015 EMERGENCY NURSES ASSN 2011 third_quarter PHA S. 296, Drug Shortage Bill Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-20T02:44:59.323000-04:00
1163129 VAN SCOYOC ASSOCIATES 0fbc6ff5-46d2-4865-80f0-6bf1adaaf649 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2011 third_quarter PHA FDA salaries and expenses; and extramural research related issues: H.R.2112,Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-20T05:58:37.960000-04:00
1163140 VAN SCOYOC ASSOCIATES ec8d98c8-b5cd-4d80-b8e3-d654952a8cc6 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2011 third_quarter PHA FDA funding initiatives; Critical Path Partnership. H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-20T05:58:39.163000-04:00
1163145 VAN SCOYOC ASSOCIATES 91a650d9-a725-4d60-88d0-c7f0e4e90dd0 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2011 third_quarter PHA No lobbying activity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-10-20T05:58:41.053000-04:00
1163189 BLUESTONE STRATEGIES, LLC e1afc06d-2d1d-44ca-8a3b-5847efed210b Q3 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2011 third_quarter PHA Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-20T07:24:38.460000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2447.1ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API